Effects of 17-DMAG on Non-small Cell Lung Cancer Cell Lines A549 and H1975
Being Resistant to EGFR-TKI

Background and objective In the clinical treatment of patients with non-small cell lung cancer (NSCLC), the primary and acquired resistance of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) limits its clinical application, this need to explore new strategy or method to overcom...

Full description

Bibliographic Details
Main Authors: Lei ZHAO, Fumin CAO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.02